<p>HCA Healthcare, Inc.（紐約證券交易所代碼：HCA - 獲取免費報告）主要股東 Of America Corp /De/ Bank 於 1 月 13 日星期五購買了 477 股該公司的股票。該股票的平均購買成本為每股 23.29 美元，總價值為 11,109.33 美元。此次購買在向美國證券交易委員會（SEC）提交的文件中披露，文件可通過此鏈接獲取。持有公司股票超過 10% 的主要股東需向 SEC 披露其買賣情況。</p>
<p>獲取 <strong>HCA Healthcare</strong> 警報：</p>
<h2>HCA Healthcare 股票表現</h2>
<ul>
<li>綜合醫療股票能在公開市場上成功嗎？</li>
</ul>
<p>HCA 在週五的交易中下跌 0.09 美元，報 342.25 美元。該公司的交易量為 1,114,475 股，而其平均交易量為 1,343,785 股。該公司的債務與股本比率為 69.07，速動比率為 0.97，流動比率為 1.08。HCA Healthcare, Inc.的 52 周低點為 289.98 美元，52 周高點為 417.14 美元。該公司的市值為 842.6 億美元，市盈率為 15.58，市盈增長比率為 1.10，貝塔值為 1.68。該公司的 50 日移動平均價格為 323.90 美元，200 日移動平均價格為 341.86 美元。</p>
<p>HCA Healthcare（紐約證券交易所代碼：HCA - 獲取免費報告）最近於 1 月 24 日星期五發布了季度財報。該公司報告本季度每股收益為 6.22 美元，超出分析師一致預期的 6.03 美元，超出幅度為 0.19 美元。HCA Healthcare 的淨利潤率為 8.16%，股本回報率為 586.47%。在去年同期，該公司每股收益為 5.90 美元。分析師平均預測 HCA Healthcare, Inc.在當前財政年度的每股收益將達到 24.98 美元。</p>
<h2>HCA Healthcare 增加股息</h2>
<ul>
<li>HCA Healthcare：購買 25% 下跌的四個理由</li>
</ul>
<p>該公司最近還披露了季度股息，將於 3 月 31 日星期一支付。3 月 17 日星期一的登記投資者將獲得每股 0.72 美元的股息。除息日期為 3 月 17 日星期一。這比 HCA Healthcare 之前的季度股息 0.66 美元有所增加。這代表着每年 2.88 美元的股息和 0.84% 的收益率。HCA Healthcare 的派息比率目前為 13.11%。</p>
<h2>分析師升級和降級</h2>
<p>HCA 一直是多份分析師報告的主題。美國銀行在 1 月 27 日星期一的報告中將 HCA Healthcare 的目標價從 380.00 美元下調至 370.00 美元，並對該公司給予 “買入” 評級。Cantor Fitzgerald 在 1 月 27 日星期一的研究報告中重申了 “增持” 評級，並將 HCA Healthcare 的目標價設定為 405.00 美元。KeyCorp 在 1 月 7 日星期二的報告中將 HCA Healthcare 的目標價從 420.00 美元下調至 370.00 美元，並對該股票給予 “增持” 評級。加拿大皇家銀行在 1 月 27 日星期一的研究報告中將 HCA Healthcare 的目標價從 405.00 美元下調至 384.00 美元，並對該股票給予 “跑贏大盤” 評級。最後，摩根士丹利在 12 月 17 日星期二的報告中將 HCA Healthcare 的目標價從 406.00 美元下調至 355.00 美元，並對該股票給予 “持平” 評級。一位股票研究分析師對該股票給予了賣出評級，三位給予了持有評級，十三位給予了買入評級，兩位給予了強烈買入評級。根據 MarketBeat.com 的數據，該股票的共識評級為 “適度買入”，平均目標價為 385.67 美元。</p>
<ul>
<li>HCA Healthcare：短期挫折，長期實力</li>
</ul>
<p><strong>查看我們最新的 HCA Healthcare 股票報告</strong></p>
<h2>機構資金流入和流出</h2>
<p>幾家對沖基金和其他機構投資者最近對 HCA 的持倉進行了調整。Whipplewood Advisors LLC 在第四季度新購入 HCA Healthcare 的股份，價值約 31,000 美元。Tidemark LLC 在第四季度新購入 HCA Healthcare 的股份，價值 36,000 美元。Legacy Investment Solutions LLC 在第三季度新購入 HCA Healthcare 的股份，價值 39,000 美元。Activest Wealth Management 在第四季度將其在 HCA Healthcare 的持倉增加了 1,250.0%。Activest Wealth Management 目前擁有 135 股該公司的股票，價值 40,000 美元，此前在上個季度又購買了 125 股。最後，Pinnacle Bancorp Inc.在第四季度將其在 HCA Healthcare 的持倉增加了 50.0%。Pinnacle Bancorp Inc.目前擁有 150 股該公司的股票，價值 45,000 美元，此前在上個季度又購買了 50 股。機構投資者和對沖基金持有該公司 62.73% 的股票。</p>
<h2>HCA Healthcare 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>HCA Healthcare, Inc.通過其子公司在美國擁有和運營醫院及相關醫療實體。它運營提供醫療和外科服務的一般和急性護理醫院，包括住院護理、重症監護、心臟護理、診斷和急救服務；以及門診服務，如門診手術、實驗室、放射學、呼吸治療、心臟病學和物理治療。</p>
<h2>精選文章</h2>
<ul>
<li>我們更看好的五隻股票超過 HCA Healthcare</li>
<li>哪些華爾街分析師最準確？</li>
<li>為什麼 Dollar Tree 的 Family Dollar 出售可能會引發復甦</li>
<li>經濟報告在成功投資策略中的作用</li>
<li>摩根大通：銀行業的 “NVIDIA”，有望獲得更多收益？</li>
<li>現在購買沃倫·巴菲特的三隻股票</li>
<li>購買 Chewy 股票反轉？這是現在的時機</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 HCA Healthcare 嗎？</h2>
<p>在考慮 HCA Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前購買……而 HCA Healthcare 並不在名單上。</p>
<p>雖然 HCA Healthcare 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

HCA控股

<p>HCA Healthcare, Inc.（紐約證券交易所代碼：HCA）的主要股東美國公司/德意志銀行於 1 月 13 日以每股 23.29 美元的價格購買了 477 股，總計 11,109.33 美元。此交易已向美國證券交易委員會（SEC）披露。HCA 的股票交易價格為 342.25 美元，市值為 842.6 億美元。該公司報告了上一季度每股收益（EPS）為 6.22 美元，超出預期。HCA 最近將季度股息從每股 0.66 美元提高至 0.72 美元。分析師的評級意見不一，普遍評級為 “適度買入”，平均目標價為 385.67 美元</p>

<p>HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) major shareholder Of America Corp /De/ Bank purchased 477 shares of the firm's stock in a transaction on Friday, January 13th. The stock was acquired at an average cost of $23.29 per share, with a total value of $11,109.33. The purchase was disclosed in a filing with the SEC, which is available through this link. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.</p>
<div class="lb-trans"><p>HCA Healthcare, Inc.（紐約證券交易所代碼：HCA - 獲取免費報告）主要股東 Of America Corp /De/ Bank 於 1 月 13 日星期五購買了 477 股該公司的股票。該股票的平均購買成本為每股 23.29 美元，總價值為 11,109.33 美元。此次購買在向美國證券交易委員會（SEC）提交的文件中披露，文件可通過此鏈接獲取。持有公司股票超過 10% 的主要股東需向 SEC 披露其買賣情況。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>HCA Healthcare</strong> 警報：</p>
</div><h2>HCA Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>HCA Healthcare 股票表現</h2>
</div><ul>
<li>Can Integrated Healthcare Stocks Succeed in Public Markets?</li>
</ul>
<div class="lb-trans"><ul>
<li>綜合醫療股票能在公開市場上成功嗎？</li>
</ul>
</div><p>HCA traded down $0.09 during trading on Friday, reaching $342.25. The company's stock had a trading volume of 1,114,475 shares, compared to its average volume of 1,343,785. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a market capitalization of $84.26 billion, a price-to-earnings ratio of 15.58, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company's fifty day moving average price is $323.90 and its 200-day moving average price is $341.86.</p>
<div class="lb-trans"><p>HCA 在週五的交易中下跌 0.09 美元，報 342.25 美元。該公司的交易量為 1,114,475 股，而其平均交易量為 1,343,785 股。該公司的債務與股本比率為 69.07，速動比率為 0.97，流動比率為 1.08。HCA Healthcare, Inc.的 52 周低點為 289.98 美元，52 周高點為 417.14 美元。該公司的市值為 842.6 億美元，市盈率為 15.58，市盈增長比率為 1.10，貝塔值為 1.68。該公司的 50 日移動平均價格為 323.90 美元，200 日移動平均價格為 341.86 美元。</p>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the firm posted $5.90 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>HCA Healthcare（紐約證券交易所代碼：HCA - 獲取免費報告）最近於 1 月 24 日星期五發布了季度財報。該公司報告本季度每股收益為 6.22 美元，超出分析師一致預期的 6.03 美元，超出幅度為 0.19 美元。HCA Healthcare 的淨利潤率為 8.16%，股本回報率為 586.47%。在去年同期，該公司每股收益為 5.90 美元。分析師平均預測 HCA Healthcare, Inc.在當前財政年度的每股收益將達到 24.98 美元。</p>
</div><h2>HCA Healthcare Increases Dividend</h2>
<div class="lb-trans"><h2>HCA Healthcare 增加股息</h2>
</div><ul>
<li>HCA Healthcare: 4 Reasons to Buy the 25% Dip</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare：購買 25% 下跌的四個理由</li>
</ul>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.84%. HCA Healthcare's payout ratio is currently 13.11%.</p>
<div class="lb-trans"><p>該公司最近還披露了季度股息，將於 3 月 31 日星期一支付。3 月 17 日星期一的登記投資者將獲得每股 0.72 美元的股息。除息日期為 3 月 17 日星期一。這比 HCA Healthcare 之前的季度股息 0.66 美元有所增加。這代表着每年 2.88 美元的股息和 0.84% 的收益率。HCA Healthcare 的派息比率目前為 13.11%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級和降級</h2>
</div><p>HCA has been the subject of several analyst reports. Bank of America lowered their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a &#34;buy&#34; rating for the company in a report on Monday, January 27th. Cantor Fitzgerald reissued an &#34;overweight&#34; rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. KeyCorp cut their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an &#34;overweight&#34; rating on the stock in a report on Tuesday, January 7th. Royal Bank of Canada dropped their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an &#34;outperform&#34; rating on the stock in a research report on Monday, January 27th. Finally, Morgan Stanley dropped their price objective on HCA Healthcare from $406.00 to $355.00 and set an &#34;equal weight&#34; rating on the stock in a report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $385.67.</p>
<div class="lb-trans"><p>HCA 一直是多份分析師報告的主題。美國銀行在 1 月 27 日星期一的報告中將 HCA Healthcare 的目標價從 380.00 美元下調至 370.00 美元，並對該公司給予 “買入” 評級。Cantor Fitzgerald 在 1 月 27 日星期一的研究報告中重申了 “增持” 評級，並將 HCA Healthcare 的目標價設定為 405.00 美元。KeyCorp 在 1 月 7 日星期二的報告中將 HCA Healthcare 的目標價從 420.00 美元下調至 370.00 美元，並對該股票給予 “增持” 評級。加拿大皇家銀行在 1 月 27 日星期一的研究報告中將 HCA Healthcare 的目標價從 405.00 美元下調至 384.00 美元，並對該股票給予 “跑贏大盤” 評級。最後，摩根士丹利在 12 月 17 日星期二的報告中將 HCA Healthcare 的目標價從 406.00 美元下調至 355.00 美元，並對該股票給予 “持平” 評級。一位股票研究分析師對該股票給予了賣出評級，三位給予了持有評級，十三位給予了買入評級，兩位給予了強烈買入評級。根據 MarketBeat.com 的數據，該股票的共識評級為 “適度買入”，平均目標價為 385.67 美元。</p>
</div><ul>
<li>HCA Healthcare: Temporary Setbacks, Long-Term Strength</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare：短期挫折，長期實力</li>
</ul>
</div><p><strong>View Our Latest Stock Report on HCA Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 HCA Healthcare 股票報告</strong></p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>Several hedge funds and other institutional investors have recently made changes to their positions in HCA. Whipplewood Advisors LLC acquired a new position in HCA Healthcare during the fourth quarter worth about $31,000. Tidemark LLC acquired a new stake in HCA Healthcare during the 4th quarter valued at $36,000. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the third quarter valued at $39,000. Activest Wealth Management increased its position in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after purchasing an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. boosted its stake in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after purchasing an additional 50 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.</p>
<div class="lb-trans"><p>幾家對沖基金和其他機構投資者最近對 HCA 的持倉進行了調整。Whipplewood Advisors LLC 在第四季度新購入 HCA Healthcare 的股份，價值約 31,000 美元。Tidemark LLC 在第四季度新購入 HCA Healthcare 的股份，價值 36,000 美元。Legacy Investment Solutions LLC 在第三季度新購入 HCA Healthcare 的股份，價值 39,000 美元。Activest Wealth Management 在第四季度將其在 HCA Healthcare 的持倉增加了 1,250.0%。Activest Wealth Management 目前擁有 135 股該公司的股票，價值 40,000 美元，此前在上個季度又購買了 125 股。最後，Pinnacle Bancorp Inc.在第四季度將其在 HCA Healthcare 的持倉增加了 50.0%。Pinnacle Bancorp Inc.目前擁有 150 股該公司的股票，價值 45,000 美元，此前在上個季度又購買了 50 股。機構投資者和對沖基金持有該公司 62.73% 的股票。</p>
</div><h2>HCA Healthcare Company Profile</h2>
<div class="lb-trans"><h2>HCA Healthcare 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.</p>
<div class="lb-trans"><p>HCA Healthcare, Inc.通過其子公司在美國擁有和運營醫院及相關醫療實體。它運營提供醫療和外科服務的一般和急性護理醫院，包括住院護理、重症監護、心臟護理、診斷和急救服務；以及門診服務，如門診手術、實驗室、放射學、呼吸治療、心臟病學和物理治療。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>Which Wall Street Analysts are the Most Accurate?</li>
<li>Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback</li>
<li>The Role Economic Reports Play in a Successful Investment Strategy</li>
<li>JPMorgan: The 'NVIDIA of Banking' Poised for More Gains?</li>
<li>3 Warren Buffett Stocks to Buy Now</li>
<li>Buy the Chewy Stock Reversal? Here’s Why Now Is the Time</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 HCA Healthcare</li>
<li>哪些華爾街分析師最準確？</li>
<li>為什麼 Dollar Tree 的 Family Dollar 出售可能會引發復甦</li>
<li>經濟報告在成功投資策略中的作用</li>
<li>摩根大通：銀行業的 “NVIDIA”，有望獲得更多收益？</li>
<li>現在購買沃倫·巴菲特的三隻股票</li>
<li>購買 Chewy 股票反轉？這是現在的時機</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 HCA Healthcare 嗎？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 HCA Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前購買……而 HCA Healthcare 並不在名單上。</p>
</div><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 HCA Healthcare 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

內部購買：HCA 控股（紐約證券交易所代碼：HCA）主要股東購買了 477 股股票